← Back to Patent Explorer
US4304915A Expired / Lapsed US ⏱️ 0.0 years remaining

3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them

Assignee: Sandoz AG
•
Filing: 1979-07-03
•
Granted: 1981-12-08
•
Expires: 1999-07-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The compounds of formula I <IMAGE> I wherein R1 is hydrogen or methyl, R3 is hydrogen, methyl, hydroxymethyl, carboxyl, alkoxycarbonyl of 2 to 5 carbon atoms, carbamoyl or cyano and R2 is a group (a) to (i), groups (a) to (i) having the following significances: <IMAGE> (a) wherein n is 0 or 1 and Ra, Rb, Rc and Rd independently are hydrogen or alkyl of 1 to 4 carbon atoms; <IMAGE> (b) wherein Re is hydrogen or alkyl of 1 to 4 carbon atoms; <IMAGE> (c) <IMAGE> (d) wherein Rh is halogen of atomic number of from 9 to 35; <IMAGE> (e) NHC(CH2OH)3; (f) <IMAGE> (g) <IMAGE> (h) <IMAGE> (i) wherein Ri together with Rn is o-phenylene optionally substituted by alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen of atomic number of from 9 to 35 and, when R3 is cyano, Ri together with Rn additionally is lower alkylene separating by 2 or 3 carbon atoms the nitrogen atom to which Ri is bound from the nitrogen atom to which Rn is bound and Rm is hydrogen or an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, araliphatic or aromatic moiety or an acyl moiety, with the provisos that, (A) when R1 is hydrogen and R2 is a group (b), R3 is methyl, hydroxymethyl, carbamoyl or cyano and (B) when R2 is a group (h), R3 is hydrogen, carbamoyl or cyano. The compounds are useful as antiarrhythmic, alpha -adrenergic blocking and antihypertensive agents and, when a cyano or carbamoyl group is attached in the 2-position of the indole nucleus, additionally as beta -adrenergic blocking agents.

Inventors

  • 👤 Richard Berthold

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 04:25
CPC Classifications
C; C07; C07D; C07D209/00; C07D209/02; C07D209/04; C07D209/08; B; B65; B65B; B65B13/00; B65B13/18; B65B13/24; B65B13/26; C07D209/30; C07D209/42

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 163 words
A compound having the formula Ipa ##STR82## wherein R 1 is hydrogen or methyl R 2 pa is a group (a), (b), (c) or (d), groups (a) to (d) having the following significances ##STR83## wherein n is 0 or 1 and R a , R b , R c and R d independently are hydrogen or alkyl of 1 to 4 carbon atoms; ##STR84## wherein R e is hydrogen or alkyl of 1 to 4 carbon atoms; ##STR85## wherein R h is halogen of atomic number of from 9 to 35, or is a group (i pa ) ##STR86## wherein R i pa together with R n pa is unsubstituted o-phenylene or alkylene of 2 or 3 carbon atoms and R m p is hydrogen, alkyl of 1 to 4 carbon atoms or phenyl optionally mono- or disubstituted by alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen of atomic number of from 9 to 35.
Claim 2
Dependent Claim 163 words
A compound having the formula Ipa ##STR82## wherein R 1 is hydrogen or methyl R 2 pa is a group (a), (b), (c) or (d), groups (a) to (d) having the following significances ##STR83## wherein n is 0 or 1 and R a , R b , R c and R d independently are hydrogen or alkyl of 1 to 4 carbon atoms; ##STR84## wherein R e is hydrogen or alkyl of 1 to 4 carbon atoms; ##STR85## wherein R h is halogen of atomic number of from 9 to 35, or is a group (i pa ) ##STR86## wherein R i pa together with R n pa is unsubstituted o-phenylene or alkylene of 2 or 3 carbon atoms and R m p is hydrogen, alkyl of 1 to 4 carbon atoms or phenyl optionally mono- or disubstituted by alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen of atomic number of from 9 to 35.
Claim 3
Dependent Claim 15 words
A compound of claim 1 wherein R 2 pa is a group i pa ).
Claim 4
Dependent Claim 119 words
A compound having the formula Ipb ##STR87## wherein R 1 is hydrogen or methyl and R 2 pb is a group (a), (b), (c), (d), (e), (f), (g) or (h), groups (a) to (h) having the following significances ##STR88## wherein n is 0 or 1 and R a , R b , R c and R d independently are hydrogen or alkyl of 1 to 4 carbon atoms; ##STR89## wherein R e is hydrogen or alkyl of 1 to 4 carbon atoms; ##STR90## wherein R h is halogen of atomic number of from 9 to 35; ##STR91## or is a group (i pb ) ##STR92## wherein R i pb together with R n pb is unsubstituted o-phenylene or ethylene.
Claim 5
Dependent Claim 119 words
A compound having the formula Ipb ##STR87## wherein R 1 is hydrogen or methyl and R 2 pb is a group (a), (b), (c), (d), (e), (f), (g) or (h), groups (a) to (h) having the following significances ##STR88## wherein n is 0 or 1 and R a , R b , R c and R d independently are hydrogen or alkyl of 1 to 4 carbon atoms; ##STR89## wherein R e is hydrogen or alkyl of 1 to 4 carbon atoms; ##STR90## wherein R h is halogen of atomic number of from 9 to 35; ##STR91## or is a group (i pb ) ##STR92## wherein R i pb together with R n pb is unsubstituted o-phenylene or ethylene.
Claim 6
Dependent Claim 15 words
A compound of claim 3 wherein R 2 pb is a group (i pb ).
Claim 7
Dependent Claim 17 words
A compound of claim 4 wherein R i pb together with R n pb is unsubstituted o-phenylene.
Claim 8
Dependent Claim 122 words
A compound having the formula E ##STR93## wherein R 1 is hydrogen or methyl, R 2 pa is as defined in claim 5, R 3 is cyano, and R 4 is alkyl of 1 to 12 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl, phenylalkyl of 7 to 12 carbon atoms, phenyl or phenylalkyl of 7 to 12 carbon atoms monosubstituted in the phenyl ring by alkyl of 1 to 4 carbon atoms, or mono- or independently disubstituted in the phenyl ring by halogen of atomic number of from 9 to 35, or mono- or independently di- or independently trisubstituted in the phenyl ring by alkoxy of 1 to 4 carbon atoms, or a pharmaceutically acceptable acid addition salt thereof.
Claim 9
Dependent Claim 14 words
A compound of claim 1 or 3 in pharmaceutically acceptable acid addition salt form.
Claim 10
Dependent Claim 14 words
A compound of claim 3 which is 4-{3-[4-(1,2-dihydro2-oxobenzimidazol-1-yl)piperidin-1-yl]-2-hydroxypropoxy}-1H-indole-2-carbonitrile, or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

US3705907A Cited
US3751429A Cited
US3808231A Cited
DE2337461A1 Cited
US3929793A Cited
US4076829A Cited
US4080463A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-12-07 1985-06-08 1985-12-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-12-07 1989-06-08 1989-12-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-12-07 1993-06-08 1993-12-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag